Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

NCT00089128 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Bladder Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: irinotecan hydrochloride

Sponsor

Medical University of South Carolina